Detail of the clinical trial

Title of the trial A randomised, phase 3 trial of decitabine versus patient's choice with physician's advice of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia
EudraCT number 2005-004503-11
Protocol number DACO-016
Sponsor Eisai, Inc., Woodcliff Lake, NJ, United States of America
Indications Hemato-oncology
Diagnosis acute myeloid leukemia
Population in clinical trial Elderly ( > 65 years)
Year of receiving the request to Institute (SÚKL) 2006
Date of approval by Institute (SÚKL) 27.06.2006
Date of approval by EC 09.05.2006
Date of initiation CT in ČR 02.08.2006
Date of ending CT in ČR 10.6.2013
Sites Hematologická klinika, Fakultní nemocnice Plzeň, Alej Svobody 80, 304 60 PLZEŇ-LOCHOTÍN
II. interní klinika - hematologie, Fakultní nemocnice Brno-Bohunice, Jihlavská 20, 625 00 BRNO-BOHUNICE
Nemocnice České Budějovice, a. s., Boženy Němcové 54, 370 87 ČESKÉ BUDĚJOVICE
Ústav hematologie a krevní transfuze, U Nemocnice 1, 128 20 PRAHA 2

‹‹ Back to list